The Latest in B-Cell Lymphoma ICYMI

Final ASCEND study data: Acalabrutinib beat standard of care for r/r CLL

October 23, 2020

CLL

ESMO offers new clinical practice guideline for CLL

October 21, 2020

CLL

Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rate

October 20, 2020

B Cell Lymphoma

Efforts to close the ‘AYA gap’ in lymphoma

October 20, 2020

B Cell Lymphoma

HIT-6 may help track meaningful change in chronic migraine

October 15, 2020

Migraine nerve stimulation device now available over the counter

October 14, 2020

Seven things to know about new lymphoma drug tafasitamab

October 9, 2020

Biomarker in the eye may flag neurodegeneration risk

October 8, 2020

Meta-analysis: Acalabrutinib showed better PFS and OS than other frontline CLL therapies

October 7, 2020

CLL

Stroke may be the first symptom of COVID-19 in younger patients

October 6, 2020

Nerve damage linked to prone positioning in COVID-19

October 2, 2020

OTC ‘brain boosters’ may pose serious risks, experts say

September 30, 2020

Two new protein biomarkers may serve as prognostic indicators for outcomes in CLL

September 23, 2020

CLL

Survey quantifies COVID-19’s impact on oncology

September 20, 2020

In MS, serious adverse effects are more common in rituximab versus ocrelizumab

September 11, 2020